Gamma Investing LLC Neuro Pace Inc Transaction History
Gamma Investing LLC
- $1.58 Trillion
- Q2 2025
A detailed history of Gamma Investing LLC transactions in Neuro Pace Inc stock. As of the latest transaction made, Gamma Investing LLC holds 402 shares of NPCE stock, worth $3,650. This represents 0.0% of its overall portfolio holdings.
Number of Shares
402
Previous 352
14.2%
Holding current value
$3,650
Previous $4.33 Million
3.51%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding NPCE
# of Institutions
94Shares Held
24.8MCall Options Held
1.8KPut Options Held
300-
Orbimed Advisors LLC San Diego, CA3.41MShares$30.9 Million1.3% of portfolio
-
Polar Capital Holdings PLC London, X02.97MShares$27 Million0.24% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.61MShares$23.7 Million2.65% of portfolio
-
Morgan Stanley New York, NY2.53MShares$23 Million0.0% of portfolio
-
First Light Asset Management, LLC Edina, MN1.58MShares$14.4 Million2.5% of portfolio
About NeuroPace Inc
- Ticker NPCE
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,846,900
- Market Cap $226M
- Description
- NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...